U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864195) titled 'A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions' on Feb. 20.
Brief Summary: Liver cancer is often diagnosed too late for effective treatment. The VOCAL2 study is developing a simple, non-invasive breath test to help detect liver cancer earlier and monitor liver conditions like cirrhosis. The test analyzes tiny chemicals in exhaled breath called volatile organic compounds (VOCs) to identify signs of liver disease.
Who can take part?
Adults aged 18 or older who:
Have liver cancer (hepatocellular carcinoma or cholangiocarcinoma), or Have liver cirrhosis or primary sclerosing cholangitis, or Have tummy sympto...